Will James appointed Vice-Chair of BIA Intellectual Property Advisory Committee

The BioIndustry Association (BIA) is pleased to announce the appointment of Will James, partner at Osborne Clarke LLP, as Vice-Chair of its Intellectual Property Advisory Committee (IPAC).
 
IPAC leads the BIA’s IP policy development, drawing on the expertise and experience of its members to shape the environment for IP ownership and ensure strong IP protection for innovative life sciences and biotech companies in the UK.
 
Will has extensive expertise in patent litigation and IP strategy in the life science sector having been involved in some of the most high profile and legally significant biopharma patent disputes of the last decade and more. He is International Head of Osborne Clarke’s Life Sciences and Healthcare sector group, where he leads complex multi-jurisdictional patent disputes and advises clients on strategies for unlocking value from their IP.
 
Commenting on his appointment, Will said:

The BIA is an overwhelming force for good in the UK life sciences ecosystem, advocating strongly for its members across a range of business-critical issues.  Having been part of the IP Advisory Committee team for some years now, it is an absolute pleasure to take on the Vice-Chair role and, alongside the IPAC team, help BIA members navigate the important legal and strategic changes and challenges happening at a rapid pace in the world right now so that UK life sciences companies are in a stronger position to drive innovation and growth.